首页 > 最新文献

Kardiochirurgia I Torakochirurgia Polska最新文献

英文 中文
Hybrid procedure: mini-invasive tricuspid valve plasty with transvenous lead extraction. 混合手术:微创三尖瓣成形术与经静脉导联取出术。
IF 0.6 Q4 SURGERY Pub Date : 2024-09-01 Epub Date: 2024-09-23 DOI: 10.5114/kitp.2024.143491
Janusz Gozdek, Łukasz Tułecki, Paweł Stefańczyk, Dorota Nowosielecka, Anna Polewczyk, Andrzej Kutarski, Agnieszka Nowosielecka
{"title":"Hybrid procedure: mini-invasive tricuspid valve plasty with transvenous lead extraction.","authors":"Janusz Gozdek, Łukasz Tułecki, Paweł Stefańczyk, Dorota Nowosielecka, Anna Polewczyk, Andrzej Kutarski, Agnieszka Nowosielecka","doi":"10.5114/kitp.2024.143491","DOIUrl":"10.5114/kitp.2024.143491","url":null,"abstract":"","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523476/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142560338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
VATS-confirmed diagnosis of pericardial rupture in a polytrauma patient. 一名多发性创伤患者经 VATS 确诊为心包破裂。
IF 0.6 Q4 SURGERY Pub Date : 2024-09-01 Epub Date: 2024-09-21 DOI: 10.5114/kitp.2024.143447
Vasyl Tkalich, Yurii Nedilia, Valentyna Borysova, Oleksandr Galiiev, Sergii Savoliuk
{"title":"VATS-confirmed diagnosis of pericardial rupture in a polytrauma patient.","authors":"Vasyl Tkalich, Yurii Nedilia, Valentyna Borysova, Oleksandr Galiiev, Sergii Savoliuk","doi":"10.5114/kitp.2024.143447","DOIUrl":"10.5114/kitp.2024.143447","url":null,"abstract":"","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External iliac vein injury and acute iliofemoral deep venous thrombosis after total hip arthroplasty: a rare iatrogenic complication and its successful endovascular repair. 全髋关节置换术后髂外静脉损伤和急性髂股深静脉血栓:一种罕见的先天性并发症及其成功的血管内修复。
IF 0.6 Q4 SURGERY Pub Date : 2024-09-01 Epub Date: 2024-09-23 DOI: 10.5114/kitp.2024.143450
Görkem Yiğit, Ayla Ece Çelikten, Ufuk Türkmen, Kudret Atakan Tekin, Taner Alıç
{"title":"External iliac vein injury and acute iliofemoral deep venous thrombosis after total hip arthroplasty: a rare iatrogenic complication and its successful endovascular repair.","authors":"Görkem Yiğit, Ayla Ece Çelikten, Ufuk Türkmen, Kudret Atakan Tekin, Taner Alıç","doi":"10.5114/kitp.2024.143450","DOIUrl":"10.5114/kitp.2024.143450","url":null,"abstract":"","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523478/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142560336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceval sutureless bioprosthesis versus Trifecta sutured bioprosthesis for aortic valve replacement: immediate results of the Perfecta study. 在主动脉瓣置换术中,Perceval 无缝合生物瓣膜与 Trifecta 有缝合生物瓣膜的对比:Perfecta 研究的即时结果。
IF 0.6 Q4 SURGERY Pub Date : 2024-09-01 Epub Date: 2024-09-25 DOI: 10.5114/kitp.2024.143499
Paolo Nardi, Claudia Altieri, Calogera Pisano, Dario Buioni, Federico Agneni, Giorgia Grizzi, Martin Dakli, Alessandro Cristian Salvati, Mattia Scognamiglio, Carlo Bassano, Giovanni Ruvolo

Introduction: The Perceval sutureless biological prosthesis for aortic valve replacement has been introduced with the rationale for shortening surgical, extracorporeal circulation and aortic cross-clamping times, in order to reduce postoperative complications.

Aim: To evaluate early hemodynamic performance and immediate outcomes of implantation of the Perceval sutureless bioprosthesis in comparison with the St. Jude Trifecta sutured bioprosthesis for aortic valve replacement (Perfecta study).

Material and methods: Between December 2014 and June 2023, 281 patients underwent St. Jude Trifecta implantation (n = 220, mean age: 75.2 ±6.5 years) and Perceval implantation, when indicated (n = 61, mean age: 77.9 ±5.1 years). Concomitant CABG was performed in 73 (33%) and in 27 (44%) patients, respectively.

Results: Extracorporeal circulation and cross-clamp times were significantly shorter in Perceval patients in all aortic valve replacements (61 ±23 and 49 ±18 minutes vs. 96 ±36 and 67 ±21 minutes), and in isolated procedures (54 ±10 and 43 ±8 minutes vs. 84 ±28 and 66 ±21 minutes) (p < 0.0001, for all comparisons). Operative mortality was absent and 2.7%, respectively (p = 0.2). Postoperatively, low output cardiac syndrome (0% vs. 4.5%) and total rate of major cardiac and non-cardiac related complications (6.6% vs. 18.6%) were significantly lower in Perceval patients (p = 0.01). Echocardiography at discharge in comparison with preoperatively showed a relevant and similar decrease of mean and peak trans-aortic valve gradients for the Trifecta prosthesis (11.6 ±4.3 vs. 50 ±15.2 mm Hg; 21.6 ±7.3 vs. 78.8 ±24 mm Hg) and for the Perceval prosthesis (12.6 ±4.8 vs. 52 ±12.5 mm Hg; 22.6 ±7.9 vs. 77.8 ±16 mm Hg) (p < 0.00001, for all comparisons). Better global cardiac function was observed in Perceval patients. Concomitant multi-vessel and left main coronary artery disease (p = 0.046; HR = 4.6) and chronic pulmonary disease (p = 0.006; HR = 5.6) were detected as independent predictors of death and postoperative major complications.

Conclusions: Early hemodynamic performance appears to be satisfactory with the use of Trifecta sutured and Perceval sutureless bioprostheses. Perceval implantation allows reduction of surgical times, better preservation of myocardial contractile function and, consequently, reduction of the risk of postoperative complications.

简介:目的:评估Perceval无缝合生物人工瓣膜与St. Jude Trifecta有缝合生物人工瓣膜在主动脉瓣置换术中的早期血流动力学表现和近期疗效比较(Perfecta研究).材料和方法:2014年12月至2023年6月期间,281名患者接受了St. Jude Trifecta人工瓣膜植入术(n = 220)和Perceval人工瓣膜植入术(n = 220):2014年12月至2023年6月期间,281名患者接受了St. Jude Trifecta植入术(n = 220,平均年龄:75.2 ± 6.5岁)和Perceval植入术(n = 61,平均年龄:77.9 ± 5.1岁)。分别有 73 例(33%)和 27 例(44%)患者同时进行了 CABG:在所有主动脉瓣置换术中,Perceval 患者的体外循环和交叉钳夹时间明显缩短(61 ±23 分钟和 49 ±18 分钟 vs. 96 ±36 分钟和 67 ±21 分钟),在孤立手术中,体外循环和交叉钳夹时间也明显缩短(54 ±10 分钟和 43 ±8 分钟 vs. 84 ±28 分钟和 66 ±21 分钟)(所有比较中,P < 0.0001)。手术死亡率分别为0.7%和2.7%(P = 0.2)。术后,低输出量心脏综合征(0% 对 4.5%)和主要心脏和非心脏相关并发症总发生率(6.6% 对 18.6%)在 Perceval 患者中明显较低(p = 0.01)。出院时的超声心动图显示,与术前相比,Trifecta 人工瓣膜的平均和经主动脉瓣梯度峰值均有相关的相似下降(11.6 ±4.3 vs. 50 ±15.2 mm Hg; 21.6 ±7.3 vs. 78.8 ±24 mm Hg)和 Perceval 人工瓣膜(12.6 ±4.8 vs. 52 ±12.5 mm Hg; 22.6 ±7.9 vs. 77.8 ±16 mm Hg)的经主动脉瓣梯度平均值和峰值下降幅度相似(所有比较中,P < 0.00001)。在 Perceval 患者中观察到更好的整体心脏功能。同时发现多血管和左主干冠状动脉疾病(p = 0.046;HR = 4.6)和慢性肺部疾病(p = 0.006;HR = 5.6)是死亡和术后主要并发症的独立预测因素:结论:使用Trifecta缝合生物前列腺假体和Perceval无缝合生物前列腺假体的早期血流动力学表现似乎令人满意。Perceval植入可缩短手术时间,更好地保护心肌收缩功能,从而降低术后并发症的风险。
{"title":"Perceval sutureless bioprosthesis versus Trifecta sutured bioprosthesis for aortic valve replacement: immediate results of the <i>Perfecta</i> study.","authors":"Paolo Nardi, Claudia Altieri, Calogera Pisano, Dario Buioni, Federico Agneni, Giorgia Grizzi, Martin Dakli, Alessandro Cristian Salvati, Mattia Scognamiglio, Carlo Bassano, Giovanni Ruvolo","doi":"10.5114/kitp.2024.143499","DOIUrl":"10.5114/kitp.2024.143499","url":null,"abstract":"<p><strong>Introduction: </strong>The Perceval sutureless biological prosthesis for aortic valve replacement has been introduced with the rationale for shortening surgical, extracorporeal circulation and aortic cross-clamping times, in order to reduce postoperative complications.</p><p><strong>Aim: </strong>To evaluate early hemodynamic performance and immediate outcomes of implantation of the Perceval sutureless bioprosthesis in comparison with the St. Jude Trifecta sutured bioprosthesis for aortic valve replacement (Perfecta study).</p><p><strong>Material and methods: </strong>Between December 2014 and June 2023, 281 patients underwent St. Jude Trifecta implantation (<i>n</i> = 220, mean age: 75.2 ±6.5 years) and Perceval implantation, when indicated (<i>n</i> = 61, mean age: 77.9 ±5.1 years). Concomitant CABG was performed in 73 (33%) and in 27 (44%) patients, respectively.</p><p><strong>Results: </strong>Extracorporeal circulation and cross-clamp times were significantly shorter in Perceval patients in all aortic valve replacements (61 ±23 and 49 ±18 minutes vs. 96 ±36 and 67 ±21 minutes), and in isolated procedures (54 ±10 and 43 ±8 minutes vs. 84 ±28 and 66 ±21 minutes) (<i>p</i> < 0.0001, for all comparisons). Operative mortality was absent and 2.7%, respectively (<i>p</i> = 0.2). Postoperatively, low output cardiac syndrome (0% vs. 4.5%) and total rate of major cardiac and non-cardiac related complications (6.6% vs. 18.6%) were significantly lower in Perceval patients (<i>p</i> = 0.01). Echocardiography at discharge in comparison with preoperatively showed a relevant and similar decrease of mean and peak trans-aortic valve gradients for the Trifecta prosthesis (11.6 ±4.3 vs. 50 ±15.2 mm Hg; 21.6 ±7.3 vs. 78.8 ±24 mm Hg) and for the Perceval prosthesis (12.6 ±4.8 vs. 52 ±12.5 mm Hg; 22.6 ±7.9 vs. 77.8 ±16 mm Hg) (<i>p</i> < 0.00001, for all comparisons). Better global cardiac function was observed in Perceval patients. Concomitant multi-vessel and left main coronary artery disease (<i>p</i> = 0.046; HR = 4.6) and chronic pulmonary disease (<i>p</i> = 0.006; HR = 5.6) were detected as independent predictors of death and postoperative major complications.</p><p><strong>Conclusions: </strong>Early hemodynamic performance appears to be satisfactory with the use of Trifecta sutured and Perceval sutureless bioprostheses. Perceval implantation allows reduction of surgical times, better preservation of myocardial contractile function and, consequently, reduction of the risk of postoperative complications.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523484/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical treatment of cardiac metastatic melanoma. 心脏转移性黑色素瘤的手术治疗。
IF 0.6 Q4 SURGERY Pub Date : 2024-09-01 Epub Date: 2024-08-29 DOI: 10.5114/kitp.2024.142633
Robert Kwinta, Katarzyna Kopcik

Melanoma is an aggressive neoplasm mainly affecting the skin. It has a predisposition to metastasis and it presents the highest propensity to spread to the heart, mostly through the hematologic route. Cardiac metastases frequently remain asymptomatic, even though the metastatic process to other organs is described as an advanced stage of the melanoma. Treatment methods include conservative and surgical management. Surgeries should be preferably performed at the early stages of the disease, when physicians can achieve total resections with clear margins. In some cases palliative procedures are also implemented. In 26 patients analyzed in this review, eleven cases presented favorable results of the surgery. In majority of the patients the diffuse metastatic disease led to their decease despite the surgery.

黑色素瘤是一种侵袭性肿瘤,主要侵犯皮肤。黑色素瘤有转移倾向,最容易通过血液途径转移到心脏。尽管向其他器官的转移过程被描述为黑色素瘤的晚期阶段,但心脏转移瘤常常没有症状。治疗方法包括保守治疗和手术治疗。手术最好在疾病的早期阶段进行,此时医生可以进行边缘清晰的全切除。在某些情况下,也会采取姑息治疗。在本综述分析的26例患者中,有11例手术效果良好。在大多数患者中,尽管进行了手术,但弥漫转移性疾病还是导致了他们的死亡。
{"title":"Surgical treatment of cardiac metastatic melanoma.","authors":"Robert Kwinta, Katarzyna Kopcik","doi":"10.5114/kitp.2024.142633","DOIUrl":"10.5114/kitp.2024.142633","url":null,"abstract":"<p><p>Melanoma is an aggressive neoplasm mainly affecting the skin. It has a predisposition to metastasis and it presents the highest propensity to spread to the heart, mostly through the hematologic route. Cardiac metastases frequently remain asymptomatic, even though the metastatic process to other organs is described as an advanced stage of the melanoma. Treatment methods include conservative and surgical management. Surgeries should be preferably performed at the early stages of the disease, when physicians can achieve total resections with clear margins. In some cases palliative procedures are also implemented. In 26 patients analyzed in this review, eleven cases presented favorable results of the surgery. In majority of the patients the diffuse metastatic disease led to their decease despite the surgery.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523482/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal timing of percutaneous coronary intervention in elderly patients with acute ST-segment elevation myocardial infarction presenting late. 晚期急性 ST 段抬高型心肌梗死老年患者经皮冠状动脉介入治疗的最佳时机。
IF 0.6 Q4 SURGERY Pub Date : 2024-09-01 Epub Date: 2024-09-30 DOI: 10.5114/kitp.2024.143685
Haiyan Jia, Weifeng Zhang, Shengqi Jia, Jun Zhang, Zhanwen Xu, Yaqin Li

Introduction: Primary percutaneous coronary intervention (PPCI) is an effective method for the clinical treatment of acute ST-segment elevation myocardial infarction (STEMI). For patients who miss the optimal time window, optimal management of these patients remains controversial.

Aim: To compare the effects of different timing of percutaneous coronary intervention on the long-term prognosis of elderly patients with acute ST-segment elevation myocardial infarction (STEMI) with time from symptom onset > 12 hours.

Material and methods: Elderly acute STEMI patients with time from symptom onset > 12 hours in the period from July 2021 to July 2022 in the Department of Cardiology, Affiliated Hospital of Hebei University, were randomly divided into four groups: group 1 (immediate invasive strategy, percutaneous coronary interventions (PCI) < 24 hours after symptoms onset, n = 80), group 2 (early invasive strategy, 24-< 72 hours after symptoms onset, n = 80), group 3 (delayed invasive strategy after symptoms onset, 72-< 168 hours after symptoms onset, n = 80), and group 4 (late PCI group after symptoms onset, ≥ 168 hours after symptoms onset, n = 80). Primary study end points were 12-month cardiac mortality, nonfatal myocardial infarction (MI), target-vessel revascularization, and heart failure-related rehospitalization.

Results: There were no significant differences between groups in cardiac mortality, nonfatal MI and target-vessel revascularization. During follow-up, heart failure-related rehospitalization was higher in group 1 than in the other groups (18.8% vs. 5.1% vs. 7.4% vs. 6.3%, p = 0.010). Compared with group 1, group 2, group 3 and group 4 had lower heart failure-related rehospitalization (HR = 0.250, 95% CI: 0.083-0.753, p = 0.014) (HR = 0.377, 95% CI: 0.146-0.971, p = 0.043) (HR = 0.320, 95% CI: 0.116-0.879, p = 0.027).

Conclusions: For acute STEMI patients who missed the optimal time of PCI, immediate PCI did not reduce adverse clinical outcomes.

导言:原发性经皮冠状动脉介入治疗(PPCI)是临床治疗急性ST段抬高型心肌梗死(STEMI)的有效方法。目的:比较不同经皮冠状动脉介入治疗时机对急性 ST 段抬高型心肌梗死(STEMI)老年患者(症状出现时间大于 12 小时)长期预后的影响:将2021年7月至2022年7月期间在河北大学附属医院心内科就诊的发病时间大于12小时的老年急性STEMI患者随机分为四组:第1组(即刻有创策略,症状发生后经皮冠状动脉介入治疗(PCI)< 24小时,n = 80),第2组(早期有创策略,症状发生后24-< 72小时,n = 80),第3组(症状发生后延迟有创策略,症状发生后72-< 168小时,n = 80),第4组(症状发生后晚期PCI组,症状发生后≥ 168小时,n = 80)。主要研究终点为12个月的心脏死亡率、非致死性心肌梗死(MI)、靶血管血运重建和心衰相关再住院:各组在心脏死亡率、非致命性心肌梗死和靶血管血运重建方面无明显差异。随访期间,第一组心衰相关再住院率高于其他组(18.8% vs. 5.1% vs. 7.4% vs. 6.3%,P = 0.010)。与第一组相比,第二组、第三组和第四组的心衰相关再住院率较低(HR = 0.250,95% CI:0.083-0.753,p = 0.014)(HR = 0.377,95% CI:0.146-0.971,p = 0.043)(HR = 0.320,95% CI:0.116-0.879,p = 0.027):对于错过最佳PCI时间的急性STEMI患者,立即PCI并不能减少不良临床结局。
{"title":"Optimal timing of percutaneous coronary intervention in elderly patients with acute ST-segment elevation myocardial infarction presenting late.","authors":"Haiyan Jia, Weifeng Zhang, Shengqi Jia, Jun Zhang, Zhanwen Xu, Yaqin Li","doi":"10.5114/kitp.2024.143685","DOIUrl":"10.5114/kitp.2024.143685","url":null,"abstract":"<p><strong>Introduction: </strong>Primary percutaneous coronary intervention (PPCI) is an effective method for the clinical treatment of acute ST-segment elevation myocardial infarction (STEMI). For patients who miss the optimal time window, optimal management of these patients remains controversial.</p><p><strong>Aim: </strong>To compare the effects of different timing of percutaneous coronary intervention on the long-term prognosis of elderly patients with acute ST-segment elevation myocardial infarction (STEMI) with time from symptom onset > 12 hours.</p><p><strong>Material and methods: </strong>Elderly acute STEMI patients with time from symptom onset > 12 hours in the period from July 2021 to July 2022 in the Department of Cardiology, Affiliated Hospital of Hebei University, were randomly divided into four groups: group 1 (immediate invasive strategy, percutaneous coronary interventions (PCI) < 24 hours after symptoms onset, <i>n</i> = 80), group 2 (early invasive strategy, 24-< 72 hours after symptoms onset, <i>n</i> = 80), group 3 (delayed invasive strategy after symptoms onset, 72-< 168 hours after symptoms onset, <i>n</i> = 80), and group 4 (late PCI group after symptoms onset, ≥ 168 hours after symptoms onset, <i>n</i> = 80). Primary study end points were 12-month cardiac mortality, nonfatal myocardial infarction (MI), target-vessel revascularization, and heart failure-related rehospitalization.</p><p><strong>Results: </strong>There were no significant differences between groups in cardiac mortality, nonfatal MI and target-vessel revascularization. During follow-up, heart failure-related rehospitalization was higher in group 1 than in the other groups (18.8% vs. 5.1% vs. 7.4% vs. 6.3%, <i>p</i> = 0.010). Compared with group 1, group 2, group 3 and group 4 had lower heart failure-related rehospitalization (HR = 0.250, 95% CI: 0.083-0.753, <i>p</i> = 0.014) (HR = 0.377, 95% CI: 0.146-0.971, <i>p</i> = 0.043) (HR = 0.320, 95% CI: 0.116-0.879, <i>p</i> = 0.027).</p><p><strong>Conclusions: </strong>For acute STEMI patients who missed the optimal time of PCI, immediate PCI did not reduce adverse clinical outcomes.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523474/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thirty-five years of single-center experience in cardiac myxoma surgery and related postoperative complications. 三十五年来单个中心在心脏肌瘤手术及相关术后并发症方面的经验。
IF 0.6 Q4 SURGERY Pub Date : 2024-09-01 Epub Date: 2024-09-25 DOI: 10.5114/kitp.2024.143461
Grzegorz Grudzien, Jakub Batko, Wojciech Olejek, Maciej Brzezinski, Boguslaw Kapelak, Krzysztof Bartus

Introduction: Myxoma is the most common benign primary cardiac tumor.

Aim: To present a single center's 35-year experience with myxoma surgery in terms of surgical technique and postoperative complications.

Material and methods: The data of 166 patients (56.7 ±12.6 years old, 68.1% female) with surgically removed myxoma were retrospectively analyzed. Information on blood transfusions, additional procedures and postoperative complications was collected.

Results: A median sternotomy was performed in 97.5% of patients. A right mini-thoracotomy was performed in 4 patients. Most (95.2%) patients were semi-urgent. The reason for truly urgent surgery was hemodynamic instability in 4.8% of patients. Crystalloid cardioplegia was used in 62% of cases. Postoperative complications were observed in 12% of patients. One death was observed on the first postoperative day. During hospitalization, 6 deaths (3.6%) were observed. The most common cause of death was multisystemic organ failure. There were no gender differences in mortality and complications.

Conclusions: Surgical treatment of myxomas is a relatively safe procedure with a mortality rate comparable to other types of cardiac surgery. The postoperative complication rate is low. Gender has no influence on the complication rate or type.

简介:肌瘤是最常见的良性原发性心脏肿瘤:目的:从手术技巧和术后并发症的角度介绍一个中心 35 年来在肌瘤手术方面的经验:回顾性分析了 166 例手术切除肌瘤的患者(56.7 ±12.6 岁,68.1% 为女性)的数据。收集了有关输血、附加手术和术后并发症的信息:结果:97.5%的患者进行了中位胸骨切开术。结果:97.5%的患者进行了中位胸骨切开术,4 名患者进行了右侧小胸骨切开术。大多数(95.2%)患者为半紧急手术。4.8%的患者血液动力学不稳定是真正紧急手术的原因。62%的病例使用了晶体状心脏麻痹。12%的患者出现了术后并发症。一名患者在术后第一天死亡。住院期间,共观察到 6 例死亡病例(3.6%)。最常见的死因是多系统器官衰竭。死亡率和并发症方面没有性别差异:结论:肌瘤手术治疗是一种相对安全的手术,死亡率与其他类型的心脏手术相当。术后并发症发生率较低。性别对并发症发生率或类型没有影响。
{"title":"Thirty-five years of single-center experience in cardiac myxoma surgery and related postoperative complications.","authors":"Grzegorz Grudzien, Jakub Batko, Wojciech Olejek, Maciej Brzezinski, Boguslaw Kapelak, Krzysztof Bartus","doi":"10.5114/kitp.2024.143461","DOIUrl":"10.5114/kitp.2024.143461","url":null,"abstract":"<p><strong>Introduction: </strong>Myxoma is the most common benign primary cardiac tumor.</p><p><strong>Aim: </strong>To present a single center's 35-year experience with myxoma surgery in terms of surgical technique and postoperative complications.</p><p><strong>Material and methods: </strong>The data of 166 patients (56.7 ±12.6 years old, 68.1% female) with surgically removed myxoma were retrospectively analyzed. Information on blood transfusions, additional procedures and postoperative complications was collected.</p><p><strong>Results: </strong>A median sternotomy was performed in 97.5% of patients. A right mini-thoracotomy was performed in 4 patients. Most (95.2%) patients were semi-urgent. The reason for truly urgent surgery was hemodynamic instability in 4.8% of patients. Crystalloid cardioplegia was used in 62% of cases. Postoperative complications were observed in 12% of patients. One death was observed on the first postoperative day. During hospitalization, 6 deaths (3.6%) were observed. The most common cause of death was multisystemic organ failure. There were no gender differences in mortality and complications.</p><p><strong>Conclusions: </strong>Surgical treatment of myxomas is a relatively safe procedure with a mortality rate comparable to other types of cardiac surgery. The postoperative complication rate is low. Gender has no influence on the complication rate or type.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523475/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Job-Buckley syndrome: a case report and literature review. 约伯-巴克利综合征:病例报告和文献综述。
IF 0.6 Q4 SURGERY Pub Date : 2024-09-01 Epub Date: 2024-09-25 DOI: 10.5114/kitp.2024.143460
Mohammed Ramdani, Massine M El Hammoumi, El Hassane Kabiri
{"title":"Job-Buckley syndrome: a case report and literature review.","authors":"Mohammed Ramdani, Massine M El Hammoumi, El Hassane Kabiri","doi":"10.5114/kitp.2024.143460","DOIUrl":"10.5114/kitp.2024.143460","url":null,"abstract":"","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142560339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retained broken beer bottle following penetrating thoracic trauma: challenges in diagnosis and treatment dilemma. 穿透性胸部创伤后残留的啤酒瓶碎片:诊断和治疗难题。
IF 0.6 Q4 SURGERY Pub Date : 2024-09-01 Epub Date: 2024-09-24 DOI: 10.5114/kitp.2024.143456
Konstantinos Grapatsas, Petraq Mustaqe, Agron Dogjani, Benjamin Ehle, Emmanuil Dimopoulos, Anastasia Papaporfyriou, Michail Galanis, Athanasios Papatriantafyllou, Francesk Mulita, Efstratios Koletsis, Levan Tchabashvili, Elias Liolis, Konstantinos Tasios, Andreas Antzoulas, Dimitrios Litsas, Manfred Dahm, Vasileios Leivaditis
{"title":"Retained broken beer bottle following penetrating thoracic trauma: challenges in diagnosis and treatment dilemma.","authors":"Konstantinos Grapatsas, Petraq Mustaqe, Agron Dogjani, Benjamin Ehle, Emmanuil Dimopoulos, Anastasia Papaporfyriou, Michail Galanis, Athanasios Papatriantafyllou, Francesk Mulita, Efstratios Koletsis, Levan Tchabashvili, Elias Liolis, Konstantinos Tasios, Andreas Antzoulas, Dimitrios Litsas, Manfred Dahm, Vasileios Leivaditis","doi":"10.5114/kitp.2024.143456","DOIUrl":"10.5114/kitp.2024.143456","url":null,"abstract":"","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142560340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicodemographic profile and outcomes of congenital diaphragmatic hernia with sac: experience of a paediatric referral centre. 带囊先天性膈疝的临床人口学特征和预后:一家儿科转诊中心的经验。
IF 0.6 Q4 SURGERY Pub Date : 2024-09-01 Epub Date: 2024-09-24 DOI: 10.5114/kitp.2024.143458
Jayalaxmi Shripati Aihole

Introduction: Congenital diaphragmatic hernia, in which viscera herniate into the thoracic cavity, is one of the common causes of onset of respiratory distress in neonates and children. Developmentally they may have a sac in rare cases.

Aim: To analyse the clinical profile and the outcome of congenital diaphragmatic hernia with a sac in neonates and children in a paediatric referral centre.

Material and methods: All surgically repaired patients with a congenital diaphragmatic hernia with sac, admitted and treated over a period of sixteen years from January 2005 to December 2021 in a tertiary care referral neonatal and paediatric centre, were included in this study. Forty-three children including neonates were analysed by their clinical characteristics, risk factors and mode of surgical interventions. Congenital diaphragmatic eventration and diaphragmatic hernial defects were excluded from this study.

Results: Forty-three study subjects were grouped into two groups for clinical and statistical analysis, based on their pre-operative and intra-operative findings as well their final diagnosis. Cases of left-sided congenial diaphragmatic hernia with sac (LCDHS) were included in group I (n = 30) and cases of right-sided congenital diaphragmatic hernia with sac (RCDHS) were included in group II (n = 13). Each group was further subclassified into A, B, C according to the age of presentation and side of the lesion in order to determine the prognosis in each subgroup. Level of evidence IV.

Conclusions: Mere awareness and clinical suspicion of such a rare embryological defect - a congenital diaphragmatic hernia with sac - from the attending clinicians can improve the prognosis of affected babies, avoiding morbid consequences if referred early to a tertiary care paediatric and neonatal centre.

导言先天性膈疝是指内脏疝入胸腔,是导致新生儿和儿童呼吸困难的常见原因之一。目的:分析儿科转诊中心新生儿和儿童先天性膈疝伴囊的临床特征和结果:本研究将 2005 年 1 月至 2021 年 12 月期间在一家三级护理新生儿和儿科转诊中心收治的所有经手术修复的先天性带囊膈疝患者纳入研究范围。研究人员对包括新生儿在内的 43 名患儿的临床特征、风险因素和手术干预方式进行了分析。本研究不包括先天性膈肌分离和膈疝缺损:根据术前、术中检查结果和最终诊断,43 名研究对象被分为两组进行临床和统计分析。左侧先天性膈疝伴囊(LCDHS)病例被分为第一组(30 例),右侧先天性膈疝伴囊(RCDHS)病例被分为第二组(13 例)。根据发病年龄和病变侧将每组进一步细分为 A、B、C 三组,以确定每个亚组的预后。证据等级 IV:临床医生对这种罕见的胚胎缺陷--先天性膈疝伴囊--的认识和临床怀疑可以改善患儿的预后,如果及早转诊到三级儿科和新生儿中心,可以避免病态后果。
{"title":"Clinicodemographic profile and outcomes of congenital diaphragmatic hernia with sac: experience of a paediatric referral centre.","authors":"Jayalaxmi Shripati Aihole","doi":"10.5114/kitp.2024.143458","DOIUrl":"10.5114/kitp.2024.143458","url":null,"abstract":"<p><strong>Introduction: </strong>Congenital diaphragmatic hernia, in which viscera herniate into the thoracic cavity, is one of the common causes of onset of respiratory distress in neonates and children. Developmentally they may have a sac in rare cases.</p><p><strong>Aim: </strong>To analyse the clinical profile and the outcome of congenital diaphragmatic hernia with a sac in neonates and children in a paediatric referral centre.</p><p><strong>Material and methods: </strong>All surgically repaired patients with a congenital diaphragmatic hernia with sac, admitted and treated over a period of sixteen years from January 2005 to December 2021 in a tertiary care referral neonatal and paediatric centre, were included in this study. Forty-three children including neonates were analysed by their clinical characteristics, risk factors and mode of surgical interventions. Congenital diaphragmatic eventration and diaphragmatic hernial defects were excluded from this study.</p><p><strong>Results: </strong>Forty-three study subjects were grouped into two groups for clinical and statistical analysis, based on their pre-operative and intra-operative findings as well their final diagnosis. Cases of left-sided congenial diaphragmatic hernia with sac (LCDHS) were included in group I (<i>n</i> = 30) and cases of right-sided congenital diaphragmatic hernia with sac (RCDHS) were included in group II (<i>n</i> = 13). Each group was further subclassified into A, B, C according to the age of presentation and side of the lesion in order to determine the prognosis in each subgroup. Level of evidence IV.</p><p><strong>Conclusions: </strong>Mere awareness and clinical suspicion of such a rare embryological defect - a congenital diaphragmatic hernia with sac - from the attending clinicians can improve the prognosis of affected babies, avoiding morbid consequences if referred early to a tertiary care paediatric and neonatal centre.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523481/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Kardiochirurgia I Torakochirurgia Polska
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1